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Antitumor activityAbstract The multi-component reaction of 1-benzothiopyran-4-ones with heterocyclic amines and
dimethylformamide-dimethylacetal (DMFDMA) in DMF at 150 C under controlled microwave
heating afforded novel poly-heterocyclic ring systems. Also, reaction of 3-dimethylaminomethyl-
ene-1-benzothiopyran-4-one with activemethylene derivatives was investigated. The structure of
all products was established on the bases of spectral data and elemental analyses and alternative
synthesis if possible. The prepared compounds were screened for their antitumor activity against
HCT-116 ‘‘colon’’ cancer cell line and some derivatives showed promising activity.
ª 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Multi-component reactions (MCR), an important class of or-
ganic tandem reactions, are one-pot processes with at least
three components to form a single product, which incorporates
most or even all of the starting materials (Hulme and Gore,
2003; Orru and De Greef, 2003; Domling and Ugi, 2000;
Nair et al., 2003; Zhu, 2003; Domling, 2002). The huge interest
for such multi-component reactions during the last years hasbeen oriented toward developing combinatorial chemistry
procedures, because of their high efﬁciency and convenience
of these reactions in comparison with multistage procedures.
Hence, most of the scientiﬁc efforts have been focused on
the development of multi-component procedures to prepare di-
verse heterocyclic compound libraries (Orru and De Greef,
2003). Also, the utility of MCR under microwave irradiation
in the synthesis of heterocyclic compounds enhanced the reac-
tion rates and improved the regioselectivity (Andrade et al.,
2008; Lidstrom et al., 2001; Bortolini et al., 2008; El Ashry
and Kassem, 2006; Sadek et al., 2012). 1-Benzothiopyran-4-
ones, also known as thiochromen-4-one, are an important class
of heterocycles. They serve as key intermediate for the synthe-
sis of bioactive heterocyclic ring systems (Dawood et al., 2001;
Al-Nakib et al., 1990, 1991; Ares et al., 1996; Wang et al.,
1996). Recently, we have concentrated much of our recent
work in the preparation of bioactive nitrogen-containing
624 E.M.H. Abbas et al.heterocycles (Farghaly et al., 2012; Abdel Hafez et al., 2010;
Farghaly and Abdalla, 2009; Riyadh and Farghaly, 2012; Far-
ghaly and Hassaneen, 2013; Farghaly and Mahmoud, 2013;
Gomha et al., 2013; Gomha and Abdel-Aziz, 2013; Gomha
and Khalil, 2012), and have already described simple and efﬁ-
cient procedures to prepare interesting molecules with biolog-
ical properties. We describe here the preparation, through
multi-component reactions under microwave heating, of new
poly-heterocyclic ring systems incorporating of benzothiopyra-
ne moiety that have not been reported hitherto in addition to
the study of the effects of the newly synthesized compounds on
the growth of human colon cancer cell line (HCT-116).
2. Experimental
2.1. Chemistry
Melting points were measured on an Electrothermal IA 9000
series digital melting point apparatus. IR spectra were re-
corded in potassium bromide disks on Pye Unicam SP 3300
and Shimadzu FTIR 8101 PC infrared spectrophotometers.
NMR spectra were recorded on a Varian Mercury VX-300
NMR spectrometer operating at 300 or 400 MHz for 1H-
NMR and run in deuterated dimethylsulfoxide (DMSO-d6).
Chemical shifts were related to that of the solvent. Mass spec-
tra were recorded on a Shimadzu GCMS-QP1000 EX mass
spectrometer at 70 eV. Elemental analyses were measured by
using a German made Elementar vario LIII CHNS analyzer.
3-Dimethylaminomethylene-1-benzothipyran-4-one 9 was pre-
pared as previously reported in the respective literature (Bruno
et al., 1999).
2.1.1. Reaction of 1-benzothiopyran-4-one (1) with heterocyclic
amines 2, 10–14 and DMF-DMA
Method A: A solution of appropriate heterocyclic amine deriv-
atives 2, 10–14 (1 mmol), 1-benzothiopyran-4-one (1) (1 mmol)
and dimethylformamide dimethylacetal (DMF-DMA)
(1 mmol) in dry dimethylformamide (10 mL) was heated under
reﬂux in a Milestone Microwave Labstation at 150 C for 10–
15 min (TLC). After concentration and cooling to room tem-
perature, the resulting solid product so formed was collected
by ﬁltration, washed well with EtOH, dried and recrystallized
from EtOH.
Method B: To a solution of 9 (1.095 g, 0.005 mol) in acetic
acid (20 ml) was added (0.005 mol) of the appropriate heterocy-
clic amines (2, 10–14 or 20). The mixture was heated under
reﬂux in a Milestone Microwave Labstation at 150 C for
5 min. After concentration and cooling to room temperature,
the precipitated product was collected by ﬁltration, washed well
with EtOH, dried and recrystallized from EtOH to give com-
pounds 5, 15–19 or 21, respectively. The products 5, 15–19
and 21 together with their physical constants are listed below.
2.1.1.1. 6H-Thiochromeno[3,4-e][1,2,4]triazolo[1,5-a]pyrimi-
dine (5). Yellow solid, (82% yield); mp 185–187 C; IR (KBr)
t 3057, 2970, 1595, 1496, 1263, 1234 cm1; 1H NMR
(300 MHz, DMSO-d6) d 4.20 (s, 2H, CH2), 7.45–7.64 (m,
4H, Ar-H), 8.75 (s, 1H, pyrimidine-H), 8.96 (s, 1H, triazole-
H); MS, m/z (%) 240 (M+, 100), 239 (83), 200 (63), 69 (58);
Anal. calcd for C12H8N4S (240.28): C, 59.98; H, 3.36; N,
23.32; found: C, 59.84; H, 3.23; N, 23.15%.2.1.1.2. 10-Phenyl-6H-thiochromeno[3,4-e]pyrazolo[1,5-a]pyri-
midine (15). Yellow solid, (83% yield); mp 168–170 C; IR
(KBr) t 3047, 2901, 1593, 1499, 1463, 1234 cm1; 1H NMR
(300 MHz, DMSO-d6) d 4.12 (s, 2H, CH2), 7.35 (s, 1H, pyra-
zole-H), 7.41–8.10 (m, 9H, Ar-H), 8.62 (s, 1H, pyrimidine-
H); MS, m/z (%) 316 (M++1, 24), 315 (M+, 100), 314 (89),
211 (20), 185 (17), 145 (14), 140 (17), 102 (12), 77 (66), 76
(27), 75 (13); Anal. calcd for C19H13N3S (315.39): C, 72.36;
H, 4.15; N, 13.32; found: C, 72.19; H, 4.01; N, 13.09%.
2.1.1.3. 10-Cyano-6H-thiochromeno[3,4-e]pyrazolo[1,5-a]pyri-
midine (16). Yellow solid, (76% yield); mp 218–220 C; IR
(KBr) t 3052, 2974, 2220 (CN), 1602, 1514, 1446, 1372,
1239 cm1; 1H NMR (300 MHz, DMSO-d6) d 4.17 (s, 2H,
CH2), 7.43–7.65 (m, 4H, Ar-H), 8.85 (s, 1H, pyrimidine-H),
8.91 (s, 1H, pyrazole-H); MS, m/z (%) 265 (M++1, 18),
2264 (M+, 92), 263 (100), 262 (12), 236 (11), 171 (7), 140 (9),
105 (11), 92 (6), 69 (15); Anal. calcd for C14H8N4S (264.31):
C, 63.62; H, 3.05; N, 21.20; found: C, 63.48; H, 2.98; N,
21.07%.
2.1.1.4. 6H-thiochromeno[3,4-e]tetrazolo[1,5-a]pyrimidine
(17). Yellow solid, (80% yield); mp 138–140 C; IR (KBr) t
3052, 2968, 1594, 1498, 1261, 1230 cm1; 1H NMR
(300 MHz, DMSO-d6) d 4.31 (s, 2H, CH2), 7.39–8.49 (m,
4H, Ar-H), 8.71 (s, 1H, pyrimidine-H); MS, m/z (%) 242
(M++1, 21), 241 (M+, 100), 240 (55), 212 (33),186 (87), 159
(39), 103 (33), 102 (25), 84 (63), 76 (25), 75 (28); Anal. calcd
for C11H7N5S (241.27): C, 54.76; H, 2.92; N, 29.03; found:
C, 54.58; H, 2.76; N, 28.94%.
2.1.1.5. 6H-thiochromeno[3,4-e]benzimidazo[1,2-a]pyrimidine
(18). Orange crystals, (88% yield); mp 255–256 C; IR (KBr) t
3051, 2968, 1450, 1299 cm1; 1H NMR (300 MHz, DMSO-d6)
d 4.06 (s, 2H, CH2), 7.18–8.15 (m, 8H, Ar-H), 8.85 (s, 1H,
pyrimidine-H); MS, m/z (%) 290 (M++1, 36), 289 (M+,
100), 288 (92), 287 (61), 145 (30), 144 (35), 102 (22), 77 (22),
76 (20), 75 (22); Anal. calcd for C17H11N3S (289.36): C,
70.56; H, 3.83; N, 14.52; found: C, 70.38; H, 3.64; N, 14.37%.
2.1.1.6. 6H-9,11-dimethyl-thiochromeno[3,4-e]pyrido[30,20:3,4]-
pyrazolo[1,5-a]pyrimidine (19). Yellow solid, (82% yield); mp
227–229 C; IR (KBr) t 3072, 2965, 1624, 1577, 1503, 1406,
1289, 1225 cm1; 1H NMR (300 MHz, DMSO-d6) d 1.91 (s,
3H, CH3), 2.64 (s, 3H, CH3), 4.27 (s, 2H, CH2), 7.0–7.36 (m,
4H, Ar-H), 7.58 (s, 1H, pyridine-H), 8.91 (s, 1H, pyrimidine-
H); MS, m/z (%) 319 (M++1, 30), 318 (M+, 100), 317 (62),
316 (32), 289 (8), 158 (16), 140 (6), 115 (11), 75 (7); Anal. calcd
for C18H14N4S (318.40): C, 67.90; H, 4.43; N, 17.60; found: C,
67.78; H, 4.39; N, 17.45%.
2.1.1.7. 1,2,3,4,7-Pentahydro-3-thioxo-thiochromeno[40,30:4,5]-
pyrido[2,3-d]pyrimidine-1-one (21). Yellow solid, (88% yield);
mp 352–354 C; IR (KBr) t 3423 (br, 2NH), 3058, 2978, 1714
(C = O), 1643, 1579, 1430, 1259 cm1; 1H NMR (300 MHz,
DMSO-d6) d 4.19 (s, 2H, CH2), 7.36–7.46 (m, 4H, Ar-H),
8.31 (s, 1H, pyrimidine-H), 12.0 (s, 1H, NH), 12.60 (s, 1H,
NH),; MS, m/z (%) 300 (M++1, 24), 299 (M+, 100), 298
(95), 297 (26), 239 (21), 211 (28), 210 (15), 185 (12), 140 (16),
120 (12), 106 (16), 105 (12), 92 (12), 76 (10); Anal. calcd for
C14H9N3OS2 (299.37): C, 56.17; H, 3.03; N, 14.04; found: C,
56.39; H, 3.15; N, 14.24%.
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To a solution of 9 (1.10 g, 0.005 mol) in acetic acid (20 ml) was
added activemethylene derivatives (24–27) (0.005 mol) in the
presence of ammonium acetate anhydrous (0.5 g). The mixture
was heated under reﬂux in a Milestone Microwave Labstation
at 150 C for 2 min. After concentration and cooling to room
temperature, the precipitated product was collected by ﬁltra-
tion, washed well with EtOH, dried and recrystallized from
EtOH to give compounds (28–31). The products (28–31) to-
gether with their physical constants are listed below.
2.1.2.1. 3-Cyano-1H-thiochromeno[4,3-b]pyridin-2(5H)-one
(28a). Yellow solid, (88% yield); mp 140–142 C; IR (KBr) t
3353 (NH), 3055, 2891, 2211 (CN), 1639 (C@@O), 1584, 1429,
1406, 1358, 1258 cm1; 1H NMR (300 MHz, DMSO-d6) d
4.09 (s, 2H, CH2), 6.88–7.60 (m, 4H, Ar-H), 7.87 (s, 1H, pyri-
dine-H), 12.40 (s, 1H, NH); MS, m/z (%) 240 (M+, 53), 239
(53), 238 (60), 151 (40), 149 (87), 105 (33), 104 (60), 83 (53),
77 (27), 71 (100); Anal. calcd for C13H8N2OS (240.28): C,
64.98; H, 3.36; N, 11.66; found: C, 64.73; H, 3.18; N, 11.43%.
2.1.2.2. 3-Benzoyl-1H-thiochromeno[4,3-b]pyridin-2(5H)-one
(28b). Yellow solid, (84% yield); mp 153–155 C; IR (KBr)
t 3428 (NH), 3053, 2892, 1642 (C@@O), 1582, 1437, 1359,
1325, 1256 cm1; 1H NMR (300 MHz, DMSO-d6) d 4.18 (s,
2H, CH2), 7.22–7.84 (m, 9H, Ar-H), 7.93 (s, 1H, pyridine-
H), 9.48 (s, 1H, NH); MS, m/z (%) 320 (M++1, 14), 319
(M+, 31), 318 (24), 317 (45), 285 (52), 164 (35), 147 (59), 104
(48), 85 (41), 77 (51), 76 (45), 73 (100); Anal. calcd for C19H13-
NO2S (319.38): C, 71.45; H, 4.10; N, 4.39; found: C, 71.28; H,
4.01; N, 4.18%.
2.1.2.3. Ethyl 2-methyl-5H-thiochromeno[4,3-b]pyridine-3-car-
boxylate (29). Yellow solid, (82% yield); mp 120–122 C; IR
(KBr) t 3056, 2893, 1732 (C@@O), 1584, 1429, 1406, 1359,
1258 cm1; 1H NMR (300 MHz, DMSO-d6) d 1.35 (t,
J= 7 Hz, 3H, CH3), 2.78 (s, 3H, CH3), 4.14 (s, 2H, CH2),
4.36 (q, J= 7 Hz, 2H, CH2), 7.32–7.43 (m, 9H, Ar-H), 8.17
(s, 1H, pyridine-H); MS, m/z (%) 286 (M++1, 19), 285
(M+, 57), 284 (55), 256 (38), 149 (60), 104 (15), 84 (30), 77
(38), 57 (100); Anal. calcd for C16H15NO2S (285.36): C,
67.34; H, 5.30; N, 4.91; found: C, 67.17; H, 5.21; N, 4.74%.
2.1.2.4. Indeno[2,1-e]thiochromeno[4,3-b]pyridin-8(6H)-one
(30). Yellow solid, (82% yield); mp 152–154 C; IR (KBr) t
3059, 2972, 1707 (C@@O), 1582, 1440, 1315, 1262 cm
1; 1H
NMR (300 MHz, DMSO-d6) d 3.92 (s, 2H, CH2), 7.23–8.05
(m, 8H, Ar-H), 8.83 (s, 1H, pyridine-H); MS, m/z (%) 301
(M+, 44), 300 (25), 283 (31), 282 (44), 255 (56), 190 (56), 162
(50), 135 (69), 105 (69), 85 (56), 77 (69), 55 (100); Anal. calcd
for C19H11NOS (301.36): C, 75.72; H, 3.68; N, 4.65; found: C,
75.54; H, 3.56; N, 4.42%.
2.1.2.5. Chromeno[3,4-e]thiochromeno[4,3-b]pyridin-6(8H)-
one (31). Yellow solid, (86% yield); mp 144–146 C; IR
(KBr) t 3052, 2971, 1727 (C@@O), 1595, 1490, 1412, 1328,
1264 cm1; 1H NMR (300 MHz, DMSO-d6) d 4.32 (s, 2H,
CH2), 7.30–7.72 (m, 8H, Ar-H), 8.57 (s, 1H, pyridine-H);
MS, m/z (%) 318 (M++1, 22), 317 (M+, 80), 316 (100), 315
(49), 136 (21), 75 (11); Anal. calcd for C19H11NO2S (317.36):
C, 71.91; H, 3.49; N, 4.41; found: C, 71.75; H, 3.22; N, 4.29%.2.1.3. Synthesis of compounds 32a,b
To a solution of the enaminone 9 (0.219 g, 1 mmol) in EtOH
(10 mL) was added hydrazine hydrate (1 mL) or phenylhydr-
azine (1 mL) and the mixture was heated under reﬂux in a
Milestone Microwave Labstation at 150 C for 2 min. The
reaction mixture was acidiﬁed by HCl/ice mixture and the
formed product was ﬁltered and crystallized from EtOH to
give the respective 2,4-dihydrothiochromeno[4,3-c]pyrazole
(32a) [mp 168–169 C, lit. mp 168–170 C] (Ramalingam
et al., 1977) and 2-phenyl-2,4-dihydrothiochromeno[4,3-c]pyr-
azole (32b) [mp 169–171 C, lit. mp 169–171 C] (Ramalingam
et al., 1977) in excellent yields.
2.1.4. Synthesis of 4H-thiochromeno[4,3-c]isoxazole (33)
Hydroxylamine hydrochloride (0.189 g, 1 mmol) was added to
a mixture of enaminone (3) (0.219 g, 1 mmol) and sodium eth-
oxide solution [prepared from sodium metal (0.023 g, 1
mmole) in ethanol (10 mL)]. The mixture was heated under re-
ﬂux in a Milestone Microwave Labstation at 150 C for 3 min.
After cooling the solution to room temperature, it was poured
onto water. The solid product was ﬁltered and crystallized
from ethanol to give isoxazole 33 [mp 71–73 C, lit. mp 71–
73 C] (Ramalingam et al., 1977).
2.1.5. Evaluation of the antitumor activity
The antitumor activity was evaluated on carcinoma cell lines,
namely HCT-116 cell. The cell line was grown as monolayers
in growth medium supplemented with 10% inactivated fetal
calf serum and 50 lg/ml gentamycin. The monolayers of
10,000 cells adhered at the bottom of the wells in a 96-well
microtiter plate (Falcon, NJ, USA) incubated for 24 h at
37 C in a humidiﬁed incubator with 5% CO2. The monolayers
were then washed with sterile phosphate buffered saline
(0.01 M pH 7.2) and simultaneously the cells were treated with
100 ll from different dilutions of tested compound in a fresh
maintenance medium and incubated at 37 C. A control of un-
treated cells was made in the absence of the tested compound.
Three wells were used for each concentration of the test sam-
ple. Every 24 h the observation under the inverted microscope
was made. The number of the surviving cells was determined
by staining the cells with crystal violet followed by cell lysing
using 33% glacial acetic acid and read the absorbance at
590 nm using ELISA reader after well mixing. The absorbance
values from untreated cells were considered as 100% prolifer-
ation and the percentage of viability was calculated as
[1(ODt/ODc)] · 100% where ODt is the mean optical density
of wells treated with the tested compounds and ODc is the
mean optical density of untreated cells.
3. Results and discussion
3.1. Chemistry
Multi-component reaction of benzothiopyrane 1,3-aminotria-
zole 2 and dimethylformamide-dimethylacetal (DMF-DMA)
in DMF under microwave irradiation at 150 C for 10 min.
afforded compound 5 rather than its isomeric structure 8
(Scheme 1). The conformation of compound 5 was established
on the bases of spectral data (Ms, IR, 1H NMR) and elemental
analyses. The mass spectrum of the reaction product 5 showed
N
N NH2
Ph
N
N N
Ph
626 E.M.H. Abbas et al.a molecular ion peak m/z = 240 (100%). Its 1H NMR spec-
trum revealed a singlet signal at d 8.75 ppm corresponding to
one proton at C7 (Farghaly et al., 2010) which was consistent
with the isomeric structure 5, while chemical shift of the proton
at C5 of the other isomer 8 is downﬁeld at d 9.09 (Al-Qalaf
et al., 2009). Furthermore, alternative synthesis of compound
5 was achieved via condensation of benzothiopyrane 1 with
dimethylformamide dimethylacetal (DMFDMF) to give com-
pound 9 (Bruno et al., 1999), and treatment of the product 9
with 3-aminotriazole 2 under the same reaction condition to
yield authentic product 5 (Scheme 1). In addition, literature re-
ports explained that, enaminone of the active methylene com-
pound was formed ﬁrstly then nucleophilic attack of the amino
group of the heterocyclic amine on the double bond of the
enaminone with concurrent elimination of the dimethylamine
to form intermediate 4 rather than condensation of water mol-
ecule in intermediate 6 (Al-Saleh et al., 2005; Dawood, 2005).
Also, this mechanism was established by X-ray crystallo-
graphic analysis in another report (Farghaly et al., 2010). On
the basis of these ﬁndings, structure 8 was discarded and the
isolated product from the studied reaction was assigned struc-
ture 5 (Scheme 1).
With this result in hand, we went on to study the scope of
such multi-component reactions with several heterocyclic
amine derivatives 10–14 and 1-benzothiopyran-4-one 1
and dimethylformamide-dimethylacetal (DMF-DMA) under
the same reaction conditions, afforded in each case theS
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Scheme 1 MCR of benzothiopyranone 1, aminotriazole 2 and
DMF-DMAcorresponding tetra-heterocyclic ring systems 15–17 and pen-
ta-heterocyclic ring systems 18 and 19, respectively (Scheme 2).
The structure of compounds 15–19 was established on the
bases of spectral data (Ms, IR, 1H NMR) and elemental anal-
yses (see Experimental part).
By the same way reaction of 6-amino-2-thioxopyrimidin-
4(3H)-one (20) with 1-benzothiopyran-4-one 1 and dimethyl-
formamide-dimethylacetal (DMF-DMA) in DMF under
microwave irradiation at 150 C for 15 min. gave compound
21 or its isomeric structure 22. The 1H NMR spectrum of
the product revealed a singlet signal at 8.31 ppm assigned for
pyridine-2H proton not pyridine-4H proton (Sadek et al.,
2012; Farghaly et al., 2010; Quiroga et al., 2002) which was
consistent with the isomeric structure 21 rather than the iso-
meric structure 22. Compound 21 was also obtained by an
alternative route: synthesis of compound 21 was achieved via
condensation of 6-amino-2-thioxopyrimidin-4(3H)-one (20)
with dimethylformamide dimethylacetal (DMFDMF) to give
compound 23 (Hassaneen and Abdallah, 2003), and treatment
of the product 23 with 1-benzothiopyran-4-one 1 to yield
authentic product 21 (Scheme 3).S
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reactions of the activemethylene derivatives with 1-benzothio-S
O
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Scheme 4 Reaction of enaminpyran-4-one and DMF-DMA, but all attempts to isolate pure
single products failed. So, we carried the reaction of enami-
none 9 with activemethylene under microwave irradiation.
Reaction of enaminone 9 with activemethylene derivatives
24–27 in glacial acetic acid in the presence of ammonium ace-
tate gave poly-heterocyclic ring systems 28–31, respectively
(Scheme 4). The structure of the products was assigned based
on the spectral data and elemental analyses. For example mass
spectrum of compound 31 revealed molecular ion peak at m/z
317 (80%) and its 1H NMR spectrum showed a characteristic
signal at d 8.57 ppm assignable to pyridine-2H proton. Its IR
spectra showed one carbonyl group band at 1727 cm1.
Finally, reaction of enaminone 9 with hydrazine derivatives
or hydroxyl amine under microwave heating at 150 C
afforded thiochromeno[4,3-c]pyrazole derivatives 32a,b andCN
2-COMe
O
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O
S
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O
R
S
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O
S
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N
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R: a, CN;
      b, PhCO
4
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one 9 with activemethylene.
Table 1 Cytotoxicity activity of the prepared compounds
against colon cancer cell line HCT-116 cell line.
Compd. No IC50 (lg/ml)
5 8.8
9 4.6
15 3.6
16 45.5
18 14.6
19 28.3
21 31.6
28a 2.6
28b 5.3
29 29.4
30 49.2
Doxorubicin 0.469
628 E.M.H. Abbas et al.thiochromeno[4,3-c]isoxazole 33, respectively (Scheme 5). It is
worthily mentioned that compounds 32 and 33 had been pre-
pared by Ramalingam et al. (Ramalingam et al., 1977) via a
different method.
3.2. Pharmacology
3.2.1. Anticancer activity
The in vitro anti-tumor activity of the tested compounds was
evaluated at Regional Center for Mycology and Biotechnology
at Al-Azhar University, Cairo, Egypt. Eleven compounds were
tested for their in vitro antitumor activity against HCT-116
‘‘colon’’ cancer cell line. Doxorubicin was used as a reference
drug and showed IC50 = 0.469 lg/ml. The most active com-
pounds 28a, 15, 9, 28b, 5, 18, revealed IC50 < 20 lg/ml against
HCT-116 (Table 1). 3-Dimethylaminomethylene-1-benzo-
thipyran-4-one 9 showed good activity with IC50 = 4.6 lg/ml
against HCT-116. Fused benzothiopyrane with the pyridine
ring in compound 28a increases the activity (IC50 = 2.6 lg/
ml) while, the replacement of the cyano group in compound
28a with the benzoyl group in compound 28b decreases the
activity (IC50 = 5.3 lg/ml). On the other hand, fused benzo-
thiopyrane with pyrazolo[1,5-a]pyrimidine in compound 15 in-
creases the activity with IC50 = 3.6 lg/ml against HCT-116.
The other derivatives have activity less than 3-dimethylamino-
methylene-1-benzothipyran-4-one 9.
4. Conclusion
In this context, we describe an efﬁcient MCR for the synthesis
of polyheterocyclic ring systems under microwave irradiation.
The anti-tumor activity of some of the prepared compounds
against colon cancer cell line HCT-116 was evaluated. The re-
sults demonstrate that benzothiopyrane fused with pyridine or
pyrazolopyrimidine derivatives showed good activity against
colon cancer cell line (HCT-116 cell line).
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